Biologic & Biosimilars


Much of the current research and development has focused on developing innovative biologics and speeding up the introduction and availability of biosimilars. The FDA has released various draughts and final guidance documents to assist biosimilar sponsors in developing data to support biosimilar submissions. Biosimilars are evaluated according to the FDA's criteria and regulations.

 


    Related Conference of Biologic & Biosimilars

    September 14-15, 2026

    6th International Conference on Pharmaceutical Chemistry

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    December 14-15, 2026

    5th Global Summit on Pharmaceutical Research

    Paris, France
    January 26-27, 2027

    22nd Annual Meet on Pharmaceutical Sciences

    Paris, France
    February 15-16, 2027

    23rd Annual Congress on Pharmacology and Toxicology

    Paris, France
    April 08-09, 2027

    21st World Drug Delivery Summit

    Vienna, Austria
    April 27-28, 2027

    10th European Biopharma Congress

    Paris, France
    April 27-28, 2027

    19th World Drug Delivery Summit

    Paris, France

    Biologic & Biosimilars Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in